Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone call keep HIV-Positive mothers and babies on track?

NCT ID NCT01645865

Prevention Sponsor: Elizabeth Glaser Pediatric AIDS Foundation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 11, 2026 · Updated 1 time

Summary

This trial tests whether mobile phone communication helps HIV-positive pregnant women in Kenya complete the steps that prevent passing HIV to their babies. Twenty-six health facilities are assigned to either standard care or standard care plus phone-based support for mothers, male partners, and health workers. Researchers track whether women finish key milestones from antenatal care through six weeks after delivery, including infant prophylaxis and early infant testing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
mobile phone communication between HIV-positive pregnant women, their male partners, and health care providers
What this could lead to
If it works, this could give clinics a low-cost way to keep mothers and babies on track through HIV prevention steps, from pregnancy to six weeks after birth.
What could go wrong
Phone messages may not overcome the travel, cost, and stigma barriers that keep some women from returning to care. The trial measures whether women complete key steps, not whether babies stay HIV-free.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

600 people

The number who actually took part.

Start date

May 2011

Finished

Apr 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Potential participants are recruited from participating study sites.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (female): * HIV-positive pregnant women seeking ANC at a study site * Up to 32 weeks gestation * Own or have access to a mobile phone on which they can receive calls and SMS messages Exclusion Criteria (female): * HIV-positive pregnant women who have already initiated antiretroviral treatment Inclusion Criteria (male): * Referral by pregnant female partner

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIDS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease congenital human immunodeficiency virus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AIDS Antiretroviral therapy HIV HIV infections

Contacts and locations

Locations

  • Elizabeth Glaser Pediatric AIDS Foundation

    Nairobi, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.